Gatekeepers Without Licenses: How Insurers and Corporate Chains Are Quietly Rewriting Veterinary Practice Authority

For most of the profession's history, the question of who may perform a given veterinary procedure has been answered by a single institution: the state licensing board. Boards set the standards, issue the credentials, and define the scope of practice. That framework, however imperfect, places clinical authority in the hands of bodies composed predominantly of veterinary professionals.

That framework is eroding.

Across the country, a quieter credentialing apparatus has taken root—one operated not by state regulators but by insurance underwriters, corporate practice networks, and third-party accreditation organizations. The decisions these entities make about which veterinarians may perform which procedures, work in which settings, or prescribe which treatments carry real and immediate consequences for practitioners. Yet they are almost entirely insulated from the democratic and professional accountability structures that govern state boards.

This is the credentialing squeeze—and veterinary medicine has been slow to name it, let alone resist it.

The Mechanics of Private Gatekeeping

The mechanisms are varied but the effect is consistent: non-veterinary entities are determining who practices high-value veterinary medicine.

In the malpractice insurance sector, underwriters have begun imposing procedure-specific requirements that exceed state licensing standards. A licensed DVM may hold full state authority to perform a given surgical technique, but if her insurer requires additional certification from a private body to cover that procedure, the practical effect is a practice restriction. The state never imposed it. No board reviewed the underlying clinical rationale. A risk actuary made the call.

In corporate veterinary networks—which now control an estimated 25 to 30 percent of U.S. companion animal practices and are expanding rapidly into specialty and emergency medicine—credentialing committees composed of administrators and compliance officers establish internal privileging systems. These systems determine which employed veterinarians may perform advanced diagnostics, prescribe certain drug protocols, or conduct procedures involving higher liability exposure. A veterinarian who does not meet internal benchmarks may be restricted from clinical activities she is fully licensed to perform under state law.

Third-party accreditation bodies add another layer. Voluntary accreditation from organizations like the American Animal Hospital Association carries market weight—clients recognize the credential and some insurers offer premium discounts to accredited practices. But accreditation standards increasingly touch clinical protocols, not merely facility and record-keeping standards. When accreditation effectively becomes a market prerequisite, voluntary standards function as de facto mandatory ones.

Why This Matters Beyond Individual Careers

The credentialing squeeze is not merely a career inconvenience for individual practitioners. It carries structural consequences for the profession and for animal health access.

First, it concentrates high-value clinical work. When private credentialing systems layer requirements on top of state licensing, the practitioners best positioned to meet those requirements are those with institutional backing—employed veterinarians at well-resourced corporate practices, specialists affiliated with academic centers, or DVMs with the time and capital to pursue additional certifications. Independent practitioners, rural generalists, and early-career veterinarians face disproportionate barriers. The result is a market in which clinical authority migrates toward consolidated entities that helped design the credentialing systems in the first place.

Second, it creates accountability gaps. State boards are subject to public records laws, administrative procedure requirements, and professional peer review. When a board takes disciplinary action or revises scope-of-practice rules, there is a traceable process. When a corporate credentialing committee decides that a DVM's prescription authority will be limited for a particular drug class, there is no comparable transparency, no appeal to a peer body, and no statutory standard governing the decision.

Third, it distorts the meaning of licensure. If a state license is necessary but no longer sufficient to practice the full scope of one's training, the social contract underlying licensure—rigorous education, examination, ongoing competency in exchange for practice authority—is quietly renegotiated by parties who were never part of the original agreement.

The Competitive Dimension

Organized veterinary medicine should also reckon with the competitive logic driving these developments. Corporate consolidators have a structural interest in credentialing systems that favor scale. A large practice group with dedicated compliance staff and negotiating leverage with insurers can absorb the cost of additional credentialing requirements. An independent practitioner typically cannot. If private gatekeeping systems effectively raise the cost of practicing at the highest clinical levels, consolidation becomes not merely a market trend but a policy outcome—one engineered, at least in part, through credentialing architecture.

This is not a hypothetical concern. Antitrust scholars studying human medicine have documented analogous dynamics in hospital credentialing, where privileging systems have been used to limit competition from independent physicians. The veterinary profession would be unwise to assume it is immune to the same incentive structures.

What Organized Veterinary Medicine Must Do

Reclaiming clinical authority from non-veterinary gatekeepers requires a coordinated response across several fronts.

Legislative engagement. State legislatures should be pressed to clarify that practice authority for licensed veterinarians may not be substantively restricted by private credentialing conditions that exceed board standards. Several states have enacted analogous protections for human physicians in the hospital privileging context; veterinary advocates should study those models and adapt them.

Regulatory advocacy. State boards should be encouraged to issue formal guidance asserting that clinical scope of practice is a regulatory matter, not a contractual one, and that private restrictions inconsistent with board standards warrant scrutiny. Boards that have been passive on this question need to hear from the profession.

Insurance market engagement. Veterinary PACs and professional associations should engage directly with state insurance commissioners—who regulate underwriting practices—to examine whether procedure-specific credentialing requirements in veterinary malpractice policies are actuarially justified or are functioning as market exclusion tools.

Transparency demands. Corporate practice networks operating credentialing systems that restrict licensed veterinarians' clinical activities should be required, at minimum, to disclose the standards applied, the composition of credentialing bodies, and the appeal mechanisms available to affected practitioners.

The state licensing board remains the appropriate locus of clinical authority in veterinary medicine. That authority was not granted to insurers, corporate compliance offices, or accreditation committees. Recovering it will require the profession to act with the same strategic intentionality that private gatekeepers have already demonstrated.